EQR
48
-2
SO
64
4
PVH
58
4
CVS
58
6
GILD
54
3
AIV
68
-2
VRSN
60
3
CAG
36
-10
AAP
33
4
NTRS
40
-4
FE
56
4
LEG
35
6
CMCSA
59
2
FOX
42
2
NTAP
60
-4
AXP
69
2
WY
60
4
PYPL
58
2
QRVO
47
-5
HUM
34
-7
EQR
48
-2
SO
64
4
PVH
58
4
CVS
58
6
GILD
54
3
AIV
68
-2
VRSN
60
3
CAG
36
-10
AAP
33
4
NTRS
40
-4
FE
56
4
LEG
35
6
CMCSA
59
2
FOX
42
2
NTAP
60
-4
AXP
69
2
WY
60
4
PYPL
58
2
QRVO
47
-5
HUM
34
-7
Financhill
Back

Manulife Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
80

MFC
Manulife Financial

Last Price:
29.53
Seasonality Move:
5.8%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
80
Manulife Financial (MFC) is a Buy

Is Manulife Financial a Buy, Sell or Hold?

  • The current Manulife Financial [MFC] share price is $29.53. The Score for MFC is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • MFC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MFC Stock Price Chart

What is Manulife Financial's stock price today?

  • The Manulife Financial share price today is $29.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MFC is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

MFC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.73 Buy
Relative Strength Index (14 RSI): 75.2 Buy
Chaikin Money Flow: -949745 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.26 - 28.82) Buy
Bollinger Bands (100): (25.34 - 27.62) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

MFC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.03 Buy
20-day SMA: 28.23 Buy
50-day SMA: 26.83 Buy
200-day SMA: 24.74 Buy
8-day EMA: 29.06 Buy
20-day EMA: 28.33 Buy
50-day EMA: 27.33 Buy
200-day EMA: 24.82 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Manulife Financial Earnings Growth & MFC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.21 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Manulife Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):